关注儿童睡眠需求 曼乐静®褪黑素颗粒在阿里健康首发

阿里健康
Jan 14

1月14日,国内首款由达因药业引进,用于改善6-15岁神经发育障碍儿童入睡困难的药物——曼乐静®褪黑素颗粒,在阿里健康正式上线,用户在平台凭处方并经专业药师审核后即可购买。此次新品上市,是阿里健康与达因药业于去年年底达成三年战略合作后,在“产品创新”维度快速落地的首个关键成果。阿里健康资深副总裁马立出席了此次新药上市启动会。她在发言中表示:“儿童健康,尤其是有特殊健康需求的儿童群体,是需要社会各方...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10